According to the latest research by Future Market Insights, the Pancreatic Elastase Testing Market will undergo a steady growth during 2021-2031. A gradual increase due to constant research studies being conducted and new verticals of disease treatment being opening can be seen over the mentioned forecast period. The increasing innovations and advancements in developing new therapeutic techniques and products will further boost the market.
What is Driving Demand for Pancreatic Elastase Testing Market?
Pancreatic elastase is a type of enzyme secreted by the pancreas. This enzyme breaks down fats, proteins, carbohydrates, etc. as it plays a crucial role in the digestion process.
Changes in level of pancreatic elastase helps in determining whether the pancreas are functioning in a proper manner or not. Decrease in its level indicates towards insufficiency of the pancreas.
The prominent drivers in this market are the rising levels of fat in individuals due to sedentary lifestyle and increased alcoholism most probably due increase in competition among individuals which can lead to severe stress levels.
Request for Report brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-14047
A study was published in Oxford Academic in 2016 which ventured into analysing the relationship between pancreatic elastase and diabetes mellitus. The researchers used ELISA for determining PE levels in the patients with diabetes mellitus. They concluded that, there exists a strong association between the changes in PE levels and diabetes mellitus.
Individuals affected with diabetes mellitus showed a significant decrease in amount of PE. This discovery can potentially be used to detect diabetes in suspected individuals with the help of early testing so that proper management of the disease can be done.
Diagnostic and therapeutic approach towards pancreatic insufficiency
Pancreatic insufficiency can be caused due to various types of pancreatic diseases like chronic pancreatitis, acute pancreatitis. Pancreatitis causes about 86,000 hospital admissions per year in United States. This makes it even more important to explore different and new approaches towards its management.
A study was published in Wiley Online Library which aimed to find out if a more therapeutic and diagnostic approach could be taken in treating a pancreatic insuffiency post pancreatitis. According to their findings, early diagnosis has many merits here as it prevents future complications in malabsorption of nutrition and leads to an adequate as well as timely treatment. This can be achieved with proper and timely testing of PE.
They further summarized that proper improvements in the diet will lead to maintaining of a nutritional status as per the normal values, but also avoid any complications associated with malabsorption of these nutrients.
U.S. and Canada Pancreatic Elastase Testing Market –
According to data given by American Addiction Centres, 95,000 American dies every year i.e. 261 per day die due to alcohol-related complications. Alcohol plays a major role in causing pancreatitis, which ultimately leads to pancreatic insufficiency.
This is what makes US the second most lucrative market is that of North American region. The main contributing factor behind the steady growth of this market is the availability of advanced facilities at healthcare centres.
Europe Pancreatic Elastase Testing Market –
Europe leading the pancreatic elastase testing market can be credited to continuous encouragement for the researchers in doing research and inventions related to various healthcare verticals.
For instance, ScheBo Biotech AG from Germany, inventors there created a test kit in 2021 consisting of a pancreatic elastase 1-specific antibody along with a device for sample collection and a proprietary extraction buffer. It can detect levels of elastase in faeces at a much higher accuracy than the present kits.
Who are the key manufacturing and supplying companies in Pancreatic Elastase Testing Market?
Key players:
- Novozymes
- DuPont
- AB Enzymes
- DSM
- Aum Enzymes
- BASF
- Buhlmann Diagnostics Corp
- Bioserv Diagnostics
- CHR Hansen
- Kemin
- avail
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides an in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
Pancreatic Elastase Testing Market Report Highlights:
- Detailed overview of the parent market
- Changing market dynamics in the industry
- In-depth market segmentation
- Historical, current and projected market size in terms of volume and value
- Recent industry trends and developments
- Competitive landscape
- Strategies of key players and products offered
- Potential and niche segments, geographical regions exhibiting promising growth
- A neutral perspective on market performance
- Must-have information for market players to sustain and enhance their market footprint
For Complete TOC @ https://www.futuremarketinsights.com/toc/rep-gb-14047
Key Segments
By Product Type:
- Pancreatic ELISA
- Easy Stool Extraction Device
By Application:
- Cystic fibrosis
- Diabetes mellitus
- Chronic pancreatitis
- Pancreatic Insufficiencys
By End User:
- Diagnostic Centres
- Hospitals and Clinics
- Pathology Laboratories
- Research Centres
By Region:
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Oceania
- Middle East & Africa